Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12882349.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Levels of iron are increased in the brains of Parkinson's disease (PD) patients compared to age-matched controls. This has been postulated to contribute to progression of the disease via several mechanisms including exacerbation of oxidative stress, initiation of inflammatory responses and triggering of Lewy body formation. In this minireview, we examine the putative role of iron in PD and its pharmacological chelation as a prospective therapeutic for the disease.
Medical subject headings
- Iron
- Iron Chelating Agents
- Neurons
- Parkinson Disease
- Substantia Nigra